Jeffrey Evans Email

Sr. Manager Operations & Finance . Blade Therapeutics

South San Francisco, CA

Location

j*****@blademed.com

Primary Email

Current Roles

Employees:
32
Revenue:
$5M
About
Blade Therapeutics is a private biopharmaceutical company founded on a commitment to revolutionize the treatment of debilitating, incurable fibrotic diseases that impact millions of people worldwide. The Company is an expert in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell and tissue damage responses leading to fibrosis. We are advancing a robust pipeline of potential first- and best-in-class investigational therapies for diseases of lung, liver and heart fibrosis, as well as neuro-degenerative diseases. This includes multiple small-molecule direct inhibitors of autotaxin / LPA and dimeric calpains that offer distinct but complementary anti-fibrotic mechanisms. Since its founding in 2015, Blade has raised approximately $90 million, including investments from Deerfield Management, MPM Capital, Pfizer Ventures, One Ventures, Osage University Partners and pharma strategic investments from Bristol-Myers Squibb and Novartis Institutes for Biomedical Research. The Company has assembled critical leadership expertise supplemented by a world-class network of scientific, pharmaceutical and clinical advisors to enable efficient and successful drug development.
Blade Therapeutics Address
442 Littlefield Ave
South San Francisco, CA
United States
Blade Therapeutics Email

Past Companies

Blade TherapeuticsSr. Manager Operations & Finance
Principia BiopharmaSr. Associate, FP&A
Principia BiopharmaSr. Accounting Associate

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.